Open AccessThe novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine
Author(s) -
Steffan T. Nawrocki,
Yingchun Han,
Valeria Visconte,
Bartlomiej Przychodzen,
Claudia M. Espitia,
James G. Phillips,
Faiz Anwer,
Anjali S. Advani,
Hetty E. Carraway,
Kevin R. Kelly,
Mikkael A. Sekeres,
Jaroslaw P. Maciejewski,
Jennifer S. Carew
Publication year - 2019
Publication title -
leukemia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.539
H-Index - 192
eISSN - 1476-5551
pISSN - 0887-6924
DOI - 10.1038/s41375-019-0529-2
Subject(s) - azacitidine , autophagy , cancer research , medicine , leukemia , biology , immunology , oncology , apoptosis , dna methylation , genetics , gene expression , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom